T-knife Therapeutics
t-knife.com
Actively hiring
Oncology Therapeutics
Cell & Gene Therapy
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Team
51-200
employees, estimated range
Backers
1
RA Capital Management
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Feb 19, 2025
Board appointment T-knife Therapeutics Welcomes Dr. Sophie Papa to its Board of Directors · bakersfield.com
Nov 6, 2023
New executive T-knife Therapeutics Announces the Appointment of Simone Silva Steiner, Ph.D., as Chief Technical Operations Officer · YahooFinance
2018
Founded
Tractionpublic signals, read monthly
Web presence
top 9%
of 133.2M domains by links, Common Crawl
Registers and programsofficial lists and records that name the company
| Legal entity | T-knife GmbH | its site |
Founders and leadersfrom filings, registers and the company's site
Elisa KiebackManaging Directorcompany's site
Backed byfrom the funds' portfolios and accelerator catalogs
RA Capital Management Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Creating next generation immunotherapy treatments for cancer and autoimmune disease.
Developing Novel Therapies from Neonatal Cardiac Progenitor Cells. Consistent, potent, and scalable neonatal cell sources designed for…
Bioarchitech develops multifunctional immunotherapies targeting cancer and virus-related diseases, including innovative viral and RNA-based…
Unleashing unconventional antigens for cancer immunotherapy. Learn about our technology.
Accelerate cancer immunotherapy and cancer vaccine development with Alithea Bio's HLA immunopeptidomics platform — neoantigen discovery…
Learn about Lyell and how we are building an industry-leading clinical-stage pipeline of CAR-T cell product candidates for cancer.
News
T-knife Therapeutics Announces Authorization of Clinical Trial Application for TK-6302, A Multi-Armored, CRISPR based T cell Therapy for Solid Tumors
- Phase 1 ATLAS trial to evaluate TK-6302 in patients with advanced PRAME-positive solid tumors authorized for initiation SAN FRANCISCO and BERLIN, March 03, 2026 (GLOBE NEWSWIRE) -- T-knife Therapeutics, Inc., a biopharmaceutical company developing next-
Read more
Report
T-knife Therapeutics
The Nature Index tracks the affiliations of scientific articles from high-quality publications. The research profile for T-knife Therapeutics reflects the research output of authors from T-knife Therapeutics who published articles in the 145 journals incl
Read more
Report
T-knife Therapeutics Announces Five Presentations at American Association for Cancer Research (AACR) Annual Meeting
Read more
Report
T-knife Therapeutics Announces the Appointment of Simone Silva Steiner, Ph.D., as Chief Technical Operations Officer
SAN FRANCISCO and BERLIN, Nov. 06, 2023 (GLOBE NEWSWIRE) -- T-knife Therapeutics, Inc., a clinical-stage biopharmaceutical company dedicated to developing T cell receptor-based immunotherapies that deliver transformational benefits to cancer patients, tod
Read more
Report
T-knife Therapeutics Presents Preclinical Data on the Anti-Tumor Activity of TK-8001 at ISCT Annual Meeting
Read more
Report
Raleigh, NC Breaking News, Weather, Traffic - WRAL NBC affiliate
Get the latest Raleigh area news, weather forecasts, I-40 traffic, ACC and high school sports, strange news and blogs for Central and Eastern North Carolina, including Raleigh, Durham, Cary, Chapel Hill, Fayetteville, Rocky Mount and Wilson.
Read more
Report
People
Elisa Kieback
Managing Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
2
Hiring now
0
Countries
2
Loading the map
Headquarters
Builds here
Office with open vacancies
No open vacancies right now Tap a pin for the office
San Francisco
United States
HQ
Berlin
Germany
Registered seat
GERMANY
Robert-Rössle-Straße 10, 13125 Berlin, Germany